Kostas Kalbakis

Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients

N. Xenidis, Maria Perraki, Maria Kafousi et al. · Journal of Clinical Oncology · 2006 · 265 citations · Full text

Medicine, Oncology, Breast Oncology +12

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Nikolaos Xenidis, Michail Ignatiadis, Stella Apostolaki et al. · Journal of Clinical Oncology · 2009 · 241 citations · Full text

Medicine, Cancer Biology, Oncology +15

Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial

Vassilis Georgoulias, Charalambos Kouroussis, N. Androulakis et al. · Journal of Clinical Oncology · 1999 · 128 citations

Medicine, Oncology, Pharmacotherapy +15

Triplet Combination With Irinotecan Plus Oxaliplatin Plus Continuous-Infusion Fluorouracil and Leucovorin as First-Line Treatment in Metastatic Colorectal Cancer: A Multicenter Phase II Trial

John Souglakos, D. Mavroudis, Stylianos Kakolyris et al. · Journal of Clinical Oncology · 2002 · 119 citations

Medicine, Oncology, Pharmacology +17

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Christos Emmanouilides, G. Sfakiotaki, Nikolaos Androulakis et al. · BMC Cancer · 2007 · 102 citations · Full text

Medicine, Oncology, Pharmacology +14